Smart Syringes Market Outlook To 2024: Key Product Categories (Auto-Disable Syringes, Active Safety Syringes, Passive Safety Syringes), Application (Drug delivery, Vaccination, Blood Specimen Collection), Regional Segmentation, Competitive Dynamics, M&A Insights, Pricing Analysis (OPP, IPP, RAP), Ands Segment Forecast

$3,650.00$6,650.00

Clear
  • Report Description
  • Table of Content
  • Highlight
  • Research Methodology
  • Request Free Sample

The global smart syringes market was valued at $5.1bn in 2016 and is anticipated to reach $10.2bn. by 2024.

 

The major factors propelling the market growth include the rising prevalence of chronic diseases, high risk of infection due to reusable syringes, an increase in geriatric population, and improvement in access to healthcare facilities across the emerging nations. Moreover, the growing preference for injectable drugs and rising demand for vaccination against such as hepatitis, polio, measles, and other diseases is expected to boost usage rates over the forecast period.

 

Smart syringes provide safety features which help in controlling and preventing the risk of infection spread. As per 2014 World Health Organization (WHO) study based on most recent data available (2010), it is observed that approximately 1.7 million people were infected with hepatitis B virus and 3,15,000 people were infected with hepatitis C virus and nearly 33,800 people were infected with HIV, due to the usage of unsafe injections.

 

Moreover, the WHO estimates suggest that 16 billion injections are administered on an average each year and 90% of injections are used for drug administration through intramuscular and intradermal routes. Furthermore, out the remaining 10%, 5% injections are utilized for immunization programs in adults and children, 5% are used for blood transfusion and other procedures. The smart syringes market is anticipated to witness strong demand over the next few years due to WHO recommendations to governments and healthcare providers to use smart syringes for all applications by 2020.

 

Smart Syringes Market 2024

 

Pricing Analysis

 

“Optimal Price Point (OPP) for Smart Syringes”

 

Estimated Average smart syringes cost – $ xx globally. However, with improving access and availability of options, OPP and range of acceptable Prices (RAP) are going to change. We at Ameri Research continuously track these prices with our proprietary pricing model.

 

The prices for standard syringes (without safety mechanism) are in the range of USD 0.03 to 0.04 when procured by UN agencies in large scale, however retail prices at hospital and clinic level might be 30% to 40% higher. Furthermore, the prices of smart syringes are estimated to be almost 100% higher (double) than standard syringes and WHO is actively engaging with all the stakeholders to increase the manufacturing, support development of new products and help in the reduction of prices over the next seven years.

 


Product Insights

 

The smart syringes market by product is segmented as auto-disable (AD) syringes, active safety syringes, and passive safety syringes. The AD syringes accounted for the largest revenue share of over 53% in 2016, due to their early adoption from several years, however the penetration has not reached its maximum potential due to pricing and large scale production constraints.

 

The passive syringes segment is expected to register the maximum CAGR of 9.5% from 2017 to 2024. The benefits of passive syringes include the automatic shielding of the needle which prevents needle stick injuries, and hospital acquired infections. Moreover, the introduction of new products from leading manufacturers such as Becton Dickinson, Medtronic, Terumo and other players is anticipated to drive the market growth over the forecast period.

 

Application and End-Use Insights

 

Based on application, the market is segmented into drug delivery, vaccination and blood specimen collection. In 2016, drug delivery accounted for the maximum share and is followed by vaccination and blood specimen collection.

 

The segmentation by end-use includes hospitals and health maintenance organizations (HMO’s, physician centers, diabetic patients, and others. Hospitals were the most dominating segment in 2016 and are expected to extend their lead over the forecast period. Hospitals have the highest patient volume and usually the pricing and quality standards play an important role in negotiating long-term purchase contracts. However, with the shift toward home healthcare and self-administration of injections, the diabetic segment is expected to grow at a faster pace over the forecast period.

 

Regional Segmentation

 

North America accounted for the maximum share of 40% in 2016 and is expected to grow at a modest CAGR over the forecast period. The North American region is mainly influenced by healthcare dollars spent in the U.S., the presence of a well-developed healthcare infrastructure, high usage of injectable drugs, continuous focus on vaccination programs, growing awareness about needlestick injuries, hospital acquired infections amongst healthcare professionals and patients.

 

Asia Pacific is anticipated to lead other regions with the highest CAGR of nearly 9% over the forecast period. The growing prevalence of chronic diseases, rise in obese population, high demand for vaccination against hepatitis, polio and other viral diseases are expected to drive the market growth over the next few years. Moreover, with the large scale production of smart syringes the prices are expected to decline, thus boosting the usage rates through the forecast period.

 

Merger and Acquisition Landscape

 

Innovation and introduction of new products in the market is crucial for market growth and sustainability. The short term and long term opportunities in the market are conducive for large manufacturers to acquire smaller players with niche portfolio or technology. Due to the growing shift toward home healthcare, companies manufacturing innovative syringes for home diabetes management, and self-drug administration are expected to see a significant growth in revenues over the next few years; These companies are prime targets for acquisition by players such as Medtronic, Becton Dickinson, B.Braun and Terumo.

 

Top Players & Company Share

 

The key market participants include B. Braun Melsungen AG, Smiths Group plc, Terumo Medical Corporation, Medtronic Plc, Baxter International, Becton Dickinson & Co, Revolutions Medical Corporation, Unilife Corporation and others. The market is highly consolidated in nature, as the majority of players are seeking the M&A route to expand into new product segments and expand their regional presence.

 

Market Segmentation

 

Smart Syringes by Product (Revenue, Million, 2014 – 2024)

  • Auto-disable syringes
  • Active safety syringes
  • Passive safety syringes

Smart Syringes by Application (Revenue, USD Million, 2014 – 2024)

  • Drug Delivery
  • Vaccination
  • Blood Specimen Collection
  • Others

Smart Syringes by End-Use (Revenue, USD Million, 2014 – 2024)

  • Hospitals and HMO’S
  • Diabetic Patients
  • Physician Practices
  • Others

Smart Syringes Regional Outlook (Revenue, USD Million, 20124- 2024)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
    • Columbia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia

Chapter 1 Methodology and Scope

  • Research Methodology
  • Research Scope & Assumptions
  • List of Data Sources

Chapter 2 Executive Summary

Chapter 3 Smart Syringes Market Overview

  • Technological Advancements in Smart Syringes
  • Disease Landscape
  • Healthcare Expenditure

Chapter 4 Smart Syringes Industry Outlook

  • Market Overview
  • Market Segmentation
  • Market Size and Growth Prospects
  • Leading Brand Dynamics
  • Key Market Drivers
    • Rising Prevalence of Chronic Diseases
    • Increasing Risk of Hospital Acquired Infections
    • Technological Advancements
    • Increasing Use of Injectable Drugs and Vaccines
  • Key Market Challenges
    • Cost constraints
    • Lack of awareness in developing nations
  • Key Opportunities Prioritized
  • Industry Analysis - Porter’s
  • Smart Syringes Market-PESTEL Analysis

Chapter 5: -Product Market Outlook

Smart Syringes Market Landscape by Product- 2016 & 2024
  • Auto-Disable Syringes
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Active Safety syringes
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Passive Safety Syringes
    • Market Landscape Analysis, 2016-2024 (USD Mn)

Chapter 6: -Application Market Outlook

Smart Syringes Market Landscape by Application- 2016 & 2024
  • Drug Delivery
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Vaccination
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Blood Specimen Collection
    • Market Landscape Analysis, 2016-2024 (USD Mn)
Chapter 7: -End-Use Market Outlook Smart Syringes Market Landscape by End-Use- 2016 & 2024
  • Hospitals and HMO’S
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Physician Centers
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Diabetic Patients
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Others
    • Market Landscape Analysis, 2016-2024 (USD Mn)
 

Chapter 8: Regional Market Outlook

Smart Syringes Market Landscape by Region- 2016
  • North America Market Landscape Analysis, 2016-2024 (USD Mn)
    • U.S. Market Landscape Analysis, 2016-2024
    • Canada Market Landscape Analysis-2016-2024
  • Europe Market Landscape Analysis, 2016-2024 (USD Mn)
    • UK Market Landscape Analysis, 2016-2024
    • Germany Market Landscape Analysis, 2016-2024
    • France Market Landscape Analysis, 2016-2024
    • Italy Market Landscape Analysis, 2016-2024
    • Spain Market Landscape Analysis, 2016-2024
  • Latin America Market Landscape Analysis, 2016-2024 (USD Mn)
    • Brazil Market Landscape Analysis, 2016-2024
    • Mexico Market Landscape Analysis, 2016-2024
    • Colombia Market Landscape Analysis, 2016-2024
  • Asia pacific Market Landscape Analysis, 2016-2024 (USD Mn)
    • Japan Market Landscape Analysis, 2016-2024
    • China Market Landscape Analysis, 2016-2024
    • India Market Landscape Analysis, 2016-2024
  • Middle East & Africa Market Landscape Analysis, 2014-2024 (USD Mn)
    • Saudi Arabia Market Landscape Analysis, 2014-2024
    • South Africa Market Landscape Analysis, 2014-2024

Chapter 9: Pricing Analysis

Optimal Price Points (OPP), Indifference price points (IPP) and Range of Acceptable Prices and (RAP) of leading brands by Region- 2016
  • North America Pricing Analysis (OPP, IPP, and RAP - 2016)
    • U.S. Pricing Analysis-2016
    • Canada Pricing Analysis-2016
  • Europe Pricing Analysis (OPP, IPP, and RAP - 2016)
    • UK Pricing Analysis-2016
    • Germany Pricing Analysis-2016
    • France Pricing Analysis-2016
    • Italy Pricing Analysis-2016
    • Spain Pricing Analysis-2016
  • Latin America Pricing Analysis (OPP, IPP, and RAP - 2016)
    • Brazil Pricing Analysis-2016
    • Mexico Pricing Analysis-2016
    • Colombia Pricing Analysis-2016
  • Asia Pacific Pricing Analysis (OPP, IPP, and RAP - 2016)
    • Japan Pricing Analysis-2016
    • China Pricing Analysis-2016
    • India Pricing Analysis-2016
  • Middle East Pricing Analysis (OPP, IPP, and RAP - 2016)
  • Saudi Arabia Pricing Analysis-2016
  • South Africa Pricing Analysis-2016

Chapter 10: Smart Syringes Pipeline Analysis

  • Executive Summary
  • Late Stage Pipeline analysis
  • Key R&D trends

Chapter 11: Smart Syringes Merger &Acquisition Outlook

  • Factors driving M&A in smart syringes market
  • Key trends and future outlook

Chapter 12: Competitive Landscape

  • Braun Melsungen AG 
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Becton, Dickinson and Company
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Terumo Corporation
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Baxter International
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Smiths Group plc
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Unilife Corporation
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Retractable Technologies, Inc.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Revolutions Medical Corporation
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
    List of Tables  
  • TABLE 1 Smart Syringes Market - Industry Snapshot & Key Buying Criteria, 2014 - 2024
  • TABLE 2 Global Smart Syringes Market, 2014 – 2024
  • TABLE 3 Global Smart Syringes Market Analysis by Product -2016
  • TABLE 4 Global Smart Syringes Market Analysis by Application-2016
  • TABLE 5 Global Smart Syringes Market Analysis by End Use -2016
  • TABLE 7 Global Smart Syringes Market Analysis by Geography-2016
  • TABLE 8 Global Smart Syringes Market Analysis by Leading Brands-2016
  • TABLE 9 Smart Syringes Market - Key market driver analysis
  • TABLE 10 Smart Syringes Market - Key market restraint analysis
  • TABLE 11 North America Market Smart Syringes Landscape Analysis, 2016-2024 (USD Mn)
  • TABLE 12U.S. Smart Syringes Market Landscape Analysis, 2016-2024
  • TABLE 13 Canada Smart Syringes Market Landscape Analysis, 2016-2024
  • TABLE 14 Europe Smart Syringes Market Landscape Analysis, 2016-2024 (USD Mn)
  • TABLE 15 U.K Smart Syringes Market Landscape Analysis, 2016-2024
  • TABLE 16 Germany Smart Syringes Market Landscape Analysis, 2016-2024
  • TABLE 17 France Smart Syringes Market Landscape Analysis, 2016-2024
  • TABLE 18 Italy Smart Syringes Market Landscape Analysis, 2016-2024
  • TABLE 19 Spain Smart Syringes Market Landscape Analysis, 2016-2024
  • TABLE 20 Latin America Smart Syringes Market Landscape Analysis, 2016-2024 (USD Mn)
  • TABLE 21 Brazil Smart Syringes Market Landscape Analysis, 2016-2024
  • TABLE 22 Mexico Smart Syringes Market Landscape Analysis, 2016-2024
  • TABLE 20 Colombia Smart Syringes Market Landscape Analysis, 2016-2024
  • TABLE 21 Asia pacific Smart Syringes Market Landscape Analysis, 2016-2024 (USD Mn)
  • TABLE 22 Japan Smart Syringes Market Landscape Analysis, 2016-2024
  • TABLE 23 China Smart Syringes Market Landscape Analysis, 2016-2024
  • TABLE 24 India Smart Syringes Market Landscape Analysis, 2016-2024
  • TABLE 25 North America Pricing Analysis
  • TABLE 26 North America Pricing Analysis (OPP, IPP, and RAP- 2016)
  • TABLE 27 U.S. Pricing Analysis-2016
  • TABLE 28 Canada Pricing Analysis-2016
  • TABLE 29 Europe Pricing Analysis (OPP, IPP, and RAP- 2016)
  • TABLE 30 U.K Pricing Analysis-2016
  • TABLE 31 Germany Pricing Analysis-2016
  • TABLE 32 France Pricing Analysis-2016
  • TABLE 33 Italy Pricing Analysis-2016
  • TABLE 34 Spain Pricing Analysis-2016
  • TABLE 35 Latin America Pricing Analysis (OPP, IPP, and RAP- 2016)
  • TABLE 36 Brazil Pricing Analysis-2016
  • TABLE 37 Mexico Pricing Analysis-2016
  • TABLE 38 Colombia Pricing Analysis-2016
  • TABLE 39 Asia Pacific Pricing Analysis (OPP, IPP, and RAP- 2016)
  • TABLE 40 Japan Pricing Analysis-2016
  • TABLE 41 China Pricing Analysis-2016
  • TABLE 42 India Pricing Analysis-2016
  • TABLE 43 Middle East Pricing Analysis (OPP, IPP, and RAP- 2016)
  • TABLE 44 Saudi Arabia Pricing Analysis-2016
  • TABLE 45 South Africa Pricing Analysis-2016
  List of Figures  
  • 1 Smart Syringes Market Segmentation
  • 2 Market Size & Growth Prospects
  • 3 Leading Brand Dynamics
  • 4 Penetration & Growth Prospects
  • 5 Industry Analysis – Porter’s
  • 6 Smart Syringes Market – PESTEL Analysis
  • 7 Smart Syringes Market Share by Product, 2016 & 2024
  • 8 Smart Syringes Market Share by Application, 2016 & 2024
  • 9 Smart Syringes Market Share by End-Use, 2016 & 2024

Key Insights Addressed:  

  • Defining market size from 2014 to 2016.
  • Estimating market growth till 2024 and consequence market forecast.
  • Identifying market drivers, restraints & future opportunities and allowing decision-maker with a range of possible outcomes and the probabilities that will occur for any choice of action.
  • Market segments and regions that will drive or lead market growth.
  • Defining Optimal Price Point (OPP) which will be accepted and recommended by maximum customers.
  • A bird’s-eye view of the competitive landscape and the key market players.
  • Key strategic growth driver adopted by market players. In-depth analysis of their strategies and implication on competition & growth.
    Key Findings:    
  • The global smart syringes market was valued at $5.1bn in 2016 and is anticipated to reach $10.2bn. by 2024.
  • As per 2014 World Health Organization (WHO) study based on most recent data available (2010), it is observed that approximately 1.7 million people were infected with hepatitis B virus and 3,15,000 people were infected with hepatitis C virus and nearly 33,800 people were infected with HIV, due to the usage of unsafe injections.
  • The prices for standard syringes (without safety mechanism) are in the range of USD 0.03 to 0.04 when procured by UN agencies in large scale, however retail prices at hospital and clinic level might be 30% to 40% higher.
  • The key market participants include B. Braun Melsungen AG, Smiths Group plc, Terumo Medical Corporation, Medtronic Plc, Baxter International, Becton Dickinson & Co, Revolutions Medical Corporation, Unilife Corporation and others.

Ameri Research implies a unique methodology of published information and primary research to bring key insights to customer decision making process. Our analytics model helps us to understand the structured and unstructured information from various sources. Key steps involves in the process are as below-

  1. Analyzing Published Information- Access to large pool of paid and unpaid published information via different sources and analyzing market trend.
  2. Setting Foundation- Input from analysis of secondary sources set our foundation to market analysis and helps in setting the scope for further research. Setting the scope involves Ameri Research proprietary statistical model, discussion with industry leaders, internal brainstorming, key discussion pointers from various forums etc.
  3. Need Gap Analysis- Defining the gap between our scope and availability of information.
  4. KOL Panel Discussion- Focused Group Discussion with a structured discussion guide to fine tune the gap and deriving the factors driving/restraining the market trend.
  5. Quantitative Research- Sampling large number of industry players, Education/Research Institutes, Government bodies, NGOs, Individual acclaimed researchers and conducting the primary interview with a structured questionnaire.
  6. Data Triangulation- We apply bottom-up demand approach or top-down estimation or a combined approach to triangulate the data points.
  7. Analyst Comment- Each of our analysts carries large pool of experience from domain perspective and add their value which is directional in nature
global-aesthetic-dermatology-market

To request a free sample copy of this report, please complete the form below verified and secure

We offer complete free customization that addresses client’s need. This includes insights from primary market research and a 60-minute free analyst consultation post report purchase.

This website is secure and your personal details are safe. Privacy policy

Description

The global smart syringes market was valued at $5.1bn in 2016 and is anticipated to reach $10.2bn. by 2024.

 

The major factors propelling the market growth include the rising prevalence of chronic diseases, high risk of infection due to reusable syringes, an increase in geriatric population, and improvement in access to healthcare facilities across the emerging nations. Moreover, the growing preference for injectable drugs and rising demand for vaccination against such as hepatitis, polio, measles, and other diseases is expected to boost usage rates over the forecast period.

 

Smart syringes provide safety features which help in controlling and preventing the risk of infection spread. As per 2014 World Health Organization (WHO) study based on most recent data available (2010), it is observed that approximately 1.7 million people were infected with hepatitis B virus and 3,15,000 people were infected with hepatitis C virus and nearly 33,800 people were infected with HIV, due to the usage of unsafe injections.

 

Moreover, the WHO estimates suggest that 16 billion injections are administered on an average each year and 90% of injections are used for drug administration through intramuscular and intradermal routes. Furthermore, out the remaining 10%, 5% injections are utilized for immunization programs in adults and children, 5% are used for blood transfusion and other procedures. The smart syringes market is anticipated to witness strong demand over the next few years due to WHO recommendations to governments and healthcare providers to use smart syringes for all applications by 2020.

 

Smart Syringes Market 2024

 

Pricing Analysis

 

“Optimal Price Point (OPP) for Smart Syringes”

 

Estimated Average smart syringes cost – $ xx globally. However, with improving access and availability of options, OPP and range of acceptable Prices (RAP) are going to change. We at Ameri Research continuously track these prices with our proprietary pricing model.

 

The prices for standard syringes (without safety mechanism) are in the range of USD 0.03 to 0.04 when procured by UN agencies in large scale, however retail prices at hospital and clinic level might be 30% to 40% higher. Furthermore, the prices of smart syringes are estimated to be almost 100% higher (double) than standard syringes and WHO is actively engaging with all the stakeholders to increase the manufacturing, support development of new products and help in the reduction of prices over the next seven years.

 


Product Insights

 

The smart syringes market by product is segmented as auto-disable (AD) syringes, active safety syringes, and passive safety syringes. The AD syringes accounted for the largest revenue share of over 53% in 2016, due to their early adoption from several years, however the penetration has not reached its maximum potential due to pricing and large scale production constraints.

 

The passive syringes segment is expected to register the maximum CAGR of 9.5% from 2017 to 2024. The benefits of passive syringes include the automatic shielding of the needle which prevents needle stick injuries, and hospital acquired infections. Moreover, the introduction of new products from leading manufacturers such as Becton Dickinson, Medtronic, Terumo and other players is anticipated to drive the market growth over the forecast period.

 

Application and End-Use Insights

 

Based on application, the market is segmented into drug delivery, vaccination and blood specimen collection. In 2016, drug delivery accounted for the maximum share and is followed by vaccination and blood specimen collection.

 

The segmentation by end-use includes hospitals and health maintenance organizations (HMO’s, physician centers, diabetic patients, and others. Hospitals were the most dominating segment in 2016 and are expected to extend their lead over the forecast period. Hospitals have the highest patient volume and usually the pricing and quality standards play an important role in negotiating long-term purchase contracts. However, with the shift toward home healthcare and self-administration of injections, the diabetic segment is expected to grow at a faster pace over the forecast period.

 

Regional Segmentation

 

North America accounted for the maximum share of 40% in 2016 and is expected to grow at a modest CAGR over the forecast period. The North American region is mainly influenced by healthcare dollars spent in the U.S., the presence of a well-developed healthcare infrastructure, high usage of injectable drugs, continuous focus on vaccination programs, growing awareness about needlestick injuries, hospital acquired infections amongst healthcare professionals and patients.

 

Asia Pacific is anticipated to lead other regions with the highest CAGR of nearly 9% over the forecast period. The growing prevalence of chronic diseases, rise in obese population, high demand for vaccination against hepatitis, polio and other viral diseases are expected to drive the market growth over the next few years. Moreover, with the large scale production of smart syringes the prices are expected to decline, thus boosting the usage rates through the forecast period.

 

Merger and Acquisition Landscape

 

Innovation and introduction of new products in the market is crucial for market growth and sustainability. The short term and long term opportunities in the market are conducive for large manufacturers to acquire smaller players with niche portfolio or technology. Due to the growing shift toward home healthcare, companies manufacturing innovative syringes for home diabetes management, and self-drug administration are expected to see a significant growth in revenues over the next few years; These companies are prime targets for acquisition by players such as Medtronic, Becton Dickinson, B.Braun and Terumo.

 

Top Players & Company Share

 

The key market participants include B. Braun Melsungen AG, Smiths Group plc, Terumo Medical Corporation, Medtronic Plc, Baxter International, Becton Dickinson & Co, Revolutions Medical Corporation, Unilife Corporation and others. The market is highly consolidated in nature, as the majority of players are seeking the M&A route to expand into new product segments and expand their regional presence.

 

Market Segmentation

 

Smart Syringes by Product (Revenue, Million, 2014 – 2024)

  • Auto-disable syringes
  • Active safety syringes
  • Passive safety syringes

Smart Syringes by Application (Revenue, USD Million, 2014 – 2024)

  • Drug Delivery
  • Vaccination
  • Blood Specimen Collection
  • Others

Smart Syringes by End-Use (Revenue, USD Million, 2014 – 2024)

  • Hospitals and HMO’S
  • Diabetic Patients
  • Physician Practices
  • Others

Smart Syringes Regional Outlook (Revenue, USD Million, 20124- 2024)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
    • Columbia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia

Additional information

Price

Single User $3,650, Multiple User $4,650, Enterprise User $6,650